Guggenheim Capital LLC boosted its position in Amdocs Limited (NASDAQ:DOX) by 2.1% during the fourth quarter, Holdings Channel reports. The firm owned 53,931 shares of the company’s stock after buying an additional 1,089 shares during the period. Guggenheim Capital LLC’s holdings in Amdocs Limited were worth $3,143,000 as of its most recent SEC filing.
Other hedge funds have also recently bought and sold shares of the company. FMR LLC raised its stake in Amdocs Limited by 9.7% in the fourth quarter. FMR LLC now owns 11,184,727 shares of the company’s stock worth $651,510,000 after buying an additional 986,604 shares during the period. Janus Capital Management LLC raised its stake in Amdocs Limited by 12.8% in the fourth quarter. Janus Capital Management LLC now owns 6,159,563 shares of the company’s stock worth $358,825,000 after buying an additional 699,284 shares during the period. Seizert Capital Partners LLC purchased a new stake in Amdocs Limited during the third quarter worth $40,347,000. Wells Fargo & Company MN raised its stake in Amdocs Limited by 26.9% in the third quarter. Wells Fargo & Company MN now owns 2,198,285 shares of the company’s stock worth $127,170,000 after buying an additional 466,314 shares during the period. Finally, FIL Ltd raised its stake in Amdocs Limited by 34.9% in the fourth quarter. FIL Ltd now owns 1,568,886 shares of the company’s stock worth $91,388,000 after buying an additional 405,705 shares during the period. 89.04% of the stock is currently owned by institutional investors and hedge funds.
Amdocs Limited (NASDAQ:DOX) opened at 62.52 on Friday. The firm has a 50-day moving average of $60.73 and a 200-day moving average of $59.45. Amdocs Limited has a 1-year low of $54.12 and a 1-year high of $62.65. The stock has a market cap of $9.17 billion, a PE ratio of 23.09 and a beta of 0.64.
Amdocs Limited (NASDAQ:DOX) last announced its earnings results on Wednesday, February 1st. The company reported $0.90 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.90 by $0.00. The business had revenue of $955 million for the quarter, compared to the consensus estimate of $954.79 million. Amdocs Limited had a net margin of 10.83% and a return on equity of 14.57%. The business’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.86 earnings per share. Analysts expect that Amdocs Limited will post $3.77 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 14th. Investors of record on Friday, March 31st will be given a dividend of $0.22 per share. This represents a $0.88 annualized dividend and a yield of 1.41%. This is a positive change from Amdocs Limited’s previous quarterly dividend of $0.20. The ex-dividend date is Wednesday, March 29th. Amdocs Limited’s payout ratio is 28.78%.
DOX has been the topic of a number of analyst reports. Zacks Investment Research lowered shares of Amdocs Limited from a “hold” rating to a “sell” rating in a report on Tuesday, January 10th. Oppenheimer Holdings Inc. reissued an “outperform” rating and issued a $65.00 price target on shares of Amdocs Limited in a research note on Thursday, December 22nd. One analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $64.17.
About Amdocs Limited
Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX).
Receive News & Ratings for Amdocs Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs Limited and related companies with MarketBeat.com's FREE daily email newsletter.